This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Dexmedetomidine
  • /
  • Comparison of Propofol and Dexmedetomidine to Trea...
Clinical trial

Comparison of Propofol and Dexmedetomidine to Treat Hyperactive and Mixed ICU Delirium - the Basel ProDex Randomized Trial

Read time: 2 mins
Last updated:1st Jan 2017
Identifier: NCT02807467
In this randomized study, the investigators aim to test the hypothesis that the reinstitution of a normal circadian rhythm by continuous infusions of dexmedetomidine compared to propofol between 8pm and 6am after diagnosis of hyperactive or mixed delirium, decreases the duration of delirium. The infusions might have to be repeated several times to achieve resolution of delirium.


Category Value
Date last updated at source 2017-01-02
Study type(s) Interventional
Expected enrolment 318
Study start date 2017-01-01
Estimated primary completion date 2020-01-01

View full details